Lyka Labs Ltd.

Financial

	Lyka Labs	Medico Remedies	Guj. Themis Biosyn
Operational Metrics
Financials
5 yr Average ROE	143.45 %	9.74 %	42.99 %
5yr average Equity Multiplier	0.43	2.35	1.49
5yr Average Asset Turnover Ratio	0.57	1.44	1.0
5yr Avg Net Profit Margin	-22.76 %	2.94 %	30.73 %
Price to Book	5.85	7.94	16.75
P/E	0.0	54.28	54.26
5yr Avg Cash Conversion Cycle	1.36 Days	15.53 Days	-29.58 Days
Inventory Days	30.5 Days	55.17 Days	20.35 Days
Days Receivable	75.65 Days	86.4 Days	52.71 Days
Days Payable	141.66 Days	139.29 Days	508.85 Days
5yr Average Interest Coverage Ratio	0.21	7.33	117.9
5yr Avg ROCE	20.41 %	14.76 %	55.36 %
5yr Avg Operating Profit Margin	19.78 %	6.57 %	43.76 %
5 yr average Debt to Equity	-0.51	0.37	0.11
5yr CAGR Net Profit	18.94 %	35.76 %	55.33 %
5yr Average Return on Assets	-5.86 %	4.38 %	29.29 %
Shareholdings
Promoter Holding	54.81 %	73.34 %	70.86 %
Share Pledged by Promoters	0.0	0.0	3.3 %
Change in Promoter Holding (3 Yrs)	34.93 %	0.0	-4.13 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.78 %

Business

	Lyka Labs	Medico Remedies	Guj. Themis Biosyn
Product Wise Break-Up	Product Wise Break-Up Formulations 96.8 Bulk Drugs 3.2 Traded Goods 0 Manufactured Goods 0 0	Product Wise Break-Up Manufactured Goods 93.05 0 Bulk Drugs 0 Traded Goods 5.57 Formulations 0 Others 1.38	Product Wise Break-Up Manufactured Goods 0 Pharmaceutical 100.0 Bulk Drugs 0 Traded Goods 0 Formulations 0
Location Wise Break-Up	Location Wise Break-Up International 52.76 India 47.24	-	-